Even in the absence of statistical differences in patients with CIN II and CIN III in the TNFR1 gene polymorphisms, we tested whether TNFR1 expressing cells were differently presented in these patients. The gene discussed is TNFRSF1A; the disease is uterine cervix carcinoma in situ.